1. Home
  2. CVAC vs SBGI Comparison

CVAC vs SBGI Comparison

Compare CVAC & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • SBGI
  • Stock Information
  • Founded
  • CVAC 2000
  • SBGI 1986
  • Country
  • CVAC Germany
  • SBGI United States
  • Employees
  • CVAC N/A
  • SBGI N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • SBGI Broadcasting
  • Sector
  • CVAC Health Care
  • SBGI Industrials
  • Exchange
  • CVAC Nasdaq
  • SBGI Nasdaq
  • Market Cap
  • CVAC 1.2B
  • SBGI 1.1B
  • IPO Year
  • CVAC 2020
  • SBGI 1995
  • Fundamental
  • Price
  • CVAC $5.48
  • SBGI $14.66
  • Analyst Decision
  • CVAC Hold
  • SBGI Buy
  • Analyst Count
  • CVAC 3
  • SBGI 6
  • Target Price
  • CVAC $6.83
  • SBGI $20.08
  • AVG Volume (30 Days)
  • CVAC 789.9K
  • SBGI 647.1K
  • Earning Date
  • CVAC 08-18-2025
  • SBGI 08-06-2025
  • Dividend Yield
  • CVAC N/A
  • SBGI 6.78%
  • EPS Growth
  • CVAC N/A
  • SBGI N/A
  • EPS
  • CVAC 0.87
  • SBGI 0.74
  • Revenue
  • CVAC $566,039,775.00
  • SBGI $3,481,000,000.00
  • Revenue This Year
  • CVAC N/A
  • SBGI N/A
  • Revenue Next Year
  • CVAC $24.04
  • SBGI $9.59
  • P/E Ratio
  • CVAC $6.35
  • SBGI $19.90
  • Revenue Growth
  • CVAC 787.60
  • SBGI 8.11
  • 52 Week Low
  • CVAC $2.37
  • SBGI $11.89
  • 52 Week High
  • CVAC $5.72
  • SBGI $18.46
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 60.60
  • SBGI 53.74
  • Support Level
  • CVAC $5.41
  • SBGI $11.89
  • Resistance Level
  • CVAC $5.54
  • SBGI $15.43
  • Average True Range (ATR)
  • CVAC 0.05
  • SBGI 0.65
  • MACD
  • CVAC -0.01
  • SBGI 0.04
  • Stochastic Oscillator
  • CVAC 73.68
  • SBGI 78.25

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About SBGI Sinclair Inc.

Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.

Share on Social Networks: